92 related articles for article (PubMed ID: 26314429)
1. [Effect of Recombinant Adenovirus AdE-SH2-Caspase 8 on the Apoptosis of Imatinib-resistant K562/G01 Cell Line].
Wang L; Fei C; Huang ZL; Li H; Liu ZL; Feng WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):976-81. PubMed ID: 26314429
[TBL] [Abstract][Full Text] [Related]
2. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
Wu RJ; Huang YQ; Ma XD
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
[TBL] [Abstract][Full Text] [Related]
3. [Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].
Li BJ; Liu TB; Wang WF; Lin MH; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):1-7. PubMed ID: 26913384
[TBL] [Abstract][Full Text] [Related]
4. [CRISPR/Cas9-mediated microRNA-21 knockout increased imatinib sensitivity in chronic myeloid leukemia cells].
Zhang Y; Wang LY; Li JZ; Jiang PF; Hu JD; Chen BY
Zhonghua Xue Ye Xue Za Zhi; 2021 Mar; 42(3):243-249. PubMed ID: 33910311
[No Abstract] [Full Text] [Related]
5. [Establishment of an imatinib resistant cell line K562/G01 and its characterization].
Qi J; Peng H; Gu ZL; Liang ZQ; Yang CZ
Zhonghua Xue Ye Xue Za Zhi; 2004 Jun; 25(6):337-41. PubMed ID: 15308010
[TBL] [Abstract][Full Text] [Related]
6. [Triptolide inhibits proliferation and induces apoptosis of imatinib resistant K562/G01 cells].
Wen SQ; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1148-52. PubMed ID: 24156423
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the Nrf2-TrxR Axis Sensitizes the Drug-Resistant Chronic Myelogenous Leukemia Cell Line K562/G01 to Imatinib Treatments.
Xu L; Zhao Y; Pan F; Zhu M; Yao L; Liu Y; Feng J; Xiong J; Chen X; Ren F; Tan Y; Wang H
Biomed Res Int; 2019; 2019():6502793. PubMed ID: 31828114
[TBL] [Abstract][Full Text] [Related]
8. Growth of chronic myeloid leukemia cells is inhibited by infection with Ad-SH2-HA adenovirus that disrupts Grb2-Bcr-Abl complexes.
Peng Z; Luo HW; Yuan Y; Shi J; Huang SF; Li CL; Cao WX; Huang ZG; Feng WL
Oncol Rep; 2011 May; 25(5):1381-8. PubMed ID: 21369701
[TBL] [Abstract][Full Text] [Related]
9. [Effects of wild type PTEN gene on proliferation, apoptosis and the influence on apoptosis key factor Bcl-2 and Caspase family on K562 cells].
Cheng ZY; Liang WT; Niu ZY; Xue F; Yao L; Pan L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):679-83. PubMed ID: 19764572
[TBL] [Abstract][Full Text] [Related]
10. [Mechanisms of recombinant adenovirus-mediated SD-HA fusion protein proliferation inhibition and induced apoptosis of K562 cells].
Huang Y; Zhang P; Du L; Gui M; Feng WL; Peng Z
Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):314-319. PubMed ID: 29779329
[No Abstract] [Full Text] [Related]
11. CUEDC2 sensitizes chronic myeloid leukemic cells to imatinib treatment.
Zhang H; Chang G; Wang J; Lin Y; Ma L; Pang T
Leuk Res; 2013 Nov; 37(11):1583-91. PubMed ID: 24125838
[TBL] [Abstract][Full Text] [Related]
12. [Construction of a recombinant adenovirus Ad5F35-SD-EGFP and its effect on K562 cell proliferation].
Shi J; Hu J; Xiao Q; Peng Z; Cao WX; Luo QP; Wang F; Feng WL
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Nov; 31(11):1806-11. PubMed ID: 22126755
[TBL] [Abstract][Full Text] [Related]
13. [Effects of Ubiquitination on the Expression of BCL6 Protein，Cell Proliferation and Apoptosis in K562/G01 Cells].
Tang HM; Ding W; Ding YH; Wu JJ; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):379-384. PubMed ID: 30998141
[TBL] [Abstract][Full Text] [Related]
14. RPS27a promotes proliferation, regulates cell cycle progression and inhibits apoptosis of leukemia cells.
Wang H; Yu J; Zhang L; Xiong Y; Chen S; Xing H; Tian Z; Tang K; Wei H; Rao Q; Wang M; Wang J
Biochem Biophys Res Commun; 2014 Apr; 446(4):1204-10. PubMed ID: 24680683
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Homoharringtonine Combined with Imatinib on the K562/G01 Cells and Its Mechanism].
Wu JJ; Ding YH; Deng ZK; Shi YY; Lu XY; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):80-84. PubMed ID: 28245379
[TBL] [Abstract][Full Text] [Related]
16. Depsipeptide (FK228) preferentially induces apoptosis in BCR/ABL-expressing cell lines and cells from patients with chronic myelogenous leukemia in blast crisis.
Okabe S; Tauchi T; Nakajima A; Sashida G; Gotoh A; Broxmeyer HE; Ohyashiki JH; Ohyashiki K
Stem Cells Dev; 2007 Jun; 16(3):503-14. PubMed ID: 17610380
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human chronic myelogenous leukemia K562 cell growth following combination treatment with resveratrol and imatinib mesylate.
Wang XJ; Li YH
Genet Mol Res; 2015 Jun; 14(2):6413-8. PubMed ID: 26125846
[TBL] [Abstract][Full Text] [Related]
18. [Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].
Shi DX; Ma LM; Lu YJ; Bai B
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):723-8. PubMed ID: 24989284
[TBL] [Abstract][Full Text] [Related]
19. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells.
Okabe S; Tauchi T; Ohyashiki K
Clin Cancer Res; 2008 Oct; 14(19):6181-6. PubMed ID: 18829496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
